Evidence map›Paper›PMID 42192674›Full record

ArticleAntibiotics (Basel, Switzerland)2026

Levofloxacin and Rifampin Resistance in

Adalucy Álvarez-Aldana, Leonardo Beltrán-Angarita, Yina Marcela Guaca-González, Manuel Alejandro Velandia-López, Lyudmila Boyanova

Abstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Association of Resistance-AssociatedAntibiotics (Basel, Switzerland) · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Adalucy Álvarez-AldanaGrupo de Investigación en Microbiología y Biotecnología (MICROBIOTEC), Programa de Microbiología, Facultad de Ciencias de la Salud, Exactas y Naturales, Universidad Libre, Pereira 660001, Colombia.ORCID 0000-0001-7460-4163
Leonardo Beltrán-AngaritaGrupo de Investigación GRIEPI, Facultad Ciencias de la Salud, Unidad Central del Valle del Cauca, Tuluá 763021, Colombia.ORCID 0000-0001-6287-6815
Yina Marcela Guaca-GonzálezGrupo Investigación Enfermedades Infecciosas (GRIENI), Programa de Medicina, Facultad Ciencias de la Salud, Universidad Tecnológica de Pereira, Pereira 660001, Colombia.ORCID 0000-0002-0527-1075
Manuel Alejandro Velandia-LópezGrupo de Investigación en Microbiología y Biotecnología (MICROBIOTEC), Programa de Microbiología, Facultad de Ciencias de la Salud, Exactas y Naturales, Universidad Libre, Pereira 660001, Colombia.
Lyudmila BoyanovaDepartment of Medical Microbiology, Medical University of Sofia, 2 Zdrave St., 1431 Sofia, Bulgaria.ORCID 0000-0001-9622-0873

Funding

Technological University of Pereira 5-13-2Universidad Libre de Colombia 12010140
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antibiotic resistanceColombiagyrA mutationsHelicobacter pylorilevofloxacinrifampin

Identifiers

PMID42192674
PMCPMC13203829

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.